Illinois Municipal Retirement Fund Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Illinois Municipal Retirement Fund cut its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 27,957 shares of the company’s stock after selling 166 shares during the period. Illinois Municipal Retirement Fund’s holdings in Prestige Consumer Healthcare were worth $1,712,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ariel Investments LLC boosted its stake in shares of Prestige Consumer Healthcare by 173.8% during the third quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock valued at $144,964,000 after purchasing an additional 1,609,044 shares during the period. Allspring Global Investments Holdings LLC boosted its position in Prestige Consumer Healthcare by 19.1% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company’s stock valued at $62,213,000 after buying an additional 174,416 shares during the period. Brandes Investment Partners LP grew its stake in Prestige Consumer Healthcare by 138.6% in the 3rd quarter. Brandes Investment Partners LP now owns 129,084 shares of the company’s stock worth $7,382,000 after acquiring an additional 74,982 shares in the last quarter. Advisors Preferred LLC bought a new position in Prestige Consumer Healthcare in the 4th quarter worth about $2,447,000. Finally, Qube Research & Technologies Ltd increased its position in shares of Prestige Consumer Healthcare by 91.4% during the third quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock worth $4,123,000 after acquiring an additional 34,430 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

PBH has been the subject of a number of research reports. TheStreet upgraded Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a report on Monday, February 12th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 10th. One investment analyst has rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $110.00.

Prestige Consumer Healthcare Trading Up 0.6 %

NYSE:PBH opened at $70.55 on Friday. The firm has a 50-day simple moving average of $70.93 and a 200-day simple moving average of $64.20. Prestige Consumer Healthcare Inc. has a one year low of $55.96 and a one year high of $75.31. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.92 and a current ratio of 3.09.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. The company had revenue of $282.74 million for the quarter, compared to analyst estimates of $280.25 million. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. Prestige Consumer Healthcare’s revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $1.04 earnings per share. On average, equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current year.

Insider Activity

In related news, SVP Mary Beth Fritz sold 5,336 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.60% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.